Alaunos Therapeutics Inc (TCRT) NPV

Sell:$3.00Buy:$3.10$0.12 (4.21%)

Prices delayed by at least 15 minutes
Sell:$3.00
Buy:$3.10
Change:$0.12 (4.21%)
Deal now
Prices delayed by at least 15 minutes
Sell:$3.00
Buy:$3.10
Change:$0.12 (4.21%)
Prices delayed by at least 15 minutes
Deal now

Company Information

About this company

Alaunos Therapeutics, Inc. is a pre-clinical obesity and metabolic disorder and clinical-stage oncology-focused cell therapy company. The Company focuses on developing small molecules that are expected to be efficacious against obesity and other metabolic disorders. The Company is engaged in developing novel small molecule-based obesity therapeutics. The Company’s operations consist primarily of conducting research and development and raising capital to fund those efforts. The Company has not generated any revenues.

Key people

Holger Weis
Chairman of the Board, Chief Executive Officer
Ferdinand Groenewald
Vice President - Finance
Michael Jerman
Director
Robert W. Postma
Independent Director
Jaime W. Vieser
Independent Director
Click to see more

Key facts

  • Shares in issue
    2.19m
  • EPIC
    TCRT
  • ISIN
    US98973P3091
  • Location
    United States
  • Sector
    Healthcare
  • Industry
    Biotechnology & Drugs
  • Market cap
    $6.56m
  • Employees
    1
  • Exchange
    NASDAQ
  • Index
  • Website
    Visit website

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.